到 2027 年亚太地区胰岛素笔市场 - 按产品类型（一次性和可重复使用）进行区域分析和预测；应用（1 型糖尿病和 2 型糖尿病）；分销渠道（医院药房、零售药房和电子商务）和地理位置
No. of Pages: 120 | Report Code: TIPRE00006392 | Category: Life Sciences
No. of Pages: 120 | Report Code: TIPRE00006392 | Category: Life Sciences
亚太地区胰岛素笔市场预计到 2027 年将达到 1,703.7 百万美元
1,703.7 百万美元 2018 年美元
743.4 百万美元。预计 2019-2027 年市场复合年增长率为 9.8%。< /strong>
老年人口增长、肥胖率上升和发病率上升等因素推动了市场的增长糖尿病。然而，由于该地区药物输送替代品的可用性以及与胰岛素笔相关的限制，市场可能会受到影响。
糖尿病是一种危及生命的慢性疾病，没有专门的治疗方法。它主要是由于人体无法产生或有效利用胰岛素激素引起的。这种能力阻碍了身体充分调节血糖水平。糖尿病有两种类型，即 I 型糖尿病（也称为乏味糖尿病）和 II 型糖尿病（也称为糖尿病）。全球范围内，糖尿病的发病率和患病率正在稳步上升。 2 型糖尿病是最常见的糖尿病形式，并且随着文化和社会的变化而增加。在高收入国家，高达 91% 的成年人患有 2 型糖尿病。
据国际糖尿病联盟估计，2013 年有 3.82 亿糖尿病患者，这个数字超出了之前的预测。在这里，超过 60% 的糖尿病患者生活在亚洲，其中近一半在中国和印度。西太平洋地区是世界上人口最多的地区，有超过1.382亿糖尿病患者，到2035年这一数字可能会增加到2.018亿。
2017 年全球糖尿病患病率
< palign=\"center\">国家/地区 | |
来源：国际糖尿病联合会
所有类型的糖尿病都会导致身体许多部位出现各种并发症。身体并会增加过早死亡的总体风险。心脏病、中风、肾衰竭、截肢、视力丧失和神经损伤是与这种疾病相关的主要并发症。
糖尿病患者需要经常监测和外部给药通过胰岛素笔和其他医疗设备提供的胰岛素。全球糖尿病患病率不断上升，预计将在预测期内推动全球胰岛素笔市场的增长。
中国是由于该国 2 型糖尿病的发病率最高以及人们的认识不断提高，预计将引领亚太地区市场。然而，糖尿病患病率的上升可能会在预测期内增加新的机会。因此，考虑到上述因素，在预测期内，该国市场的增长可能会在亚太地区贡献最大份额。
亚太地区糖尿病护理设备 –市场细分
按产品
作者
最终用户
按分销渠道
< /span>
按地理位置
公司简介
Strategic insights for Asia Pacific Insulin Pens involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 743.4 Million |
| Market Size by 2027 | US$ 1,703.7 Million |
| Global CAGR (2019 - 2027) | 9.8% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Insulin Pens refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The Asia Pacific Insulin Pens Market is valued at US$ 743.4 Million in 2018, it is projected to reach US$ 1,703.7 Million by 2027.
As per our report Asia Pacific Insulin Pens Market, the market size is valued at US$ 743.4 Million in 2018, projecting it to reach US$ 1,703.7 Million by 2027. This translates to a CAGR of approximately 9.8% during the forecast period.
The Asia Pacific Insulin Pens Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Insulin Pens Market report:
The Asia Pacific Insulin Pens Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Insulin Pens Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Insulin Pens Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Insulin Pens Market
